- Home
- FBYD vs EBS Comparison
FBYD vs EBS Comparison
Compare FBYD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBYD | EBS |
|---|---|---|
| Founded | 2021 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 821.0M | 663.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | FBYD | EBS |
|---|---|---|
| Price | $6.70 | $12.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 122.8K | ★ 978.2K |
| Earning Date | 11-14-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.01 | ★ 1.35 |
| Revenue | $9,673,000.00 | ★ $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | $1,627.16 | ★ $8.82 |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $3.62 | $4.02 |
| 52 Week High | $29.02 | $14.06 |
Technical Indicators
Market Signals| Indicator | FBYD | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 52.36 |
| Support Level | $5.81 | $10.60 |
| Resistance Level | $7.59 | $12.58 |
| Average True Range (ATR) | 1.35 | 0.73 |
| MACD | -0.34 | -0.07 |
| Stochastic Oscillator | 15.89 | 47.11 |
Price Performance
Historical ComparisonAbout FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.